Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review

November 20, 2009 by RecallAware
Filed under: Medicine 

FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo.

Source:Full Article

Tags:

Comments

Readers of this site appreciate your comments

You must be logged in to post a comment.

References and links to other sites are provided as a courtesy. The recall and safety information provided here is based entirely on manufacturers' and regulatory agencies' press release or other public information. We make no other representations about the accuracy or timeliness of this information